Mapping of Apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy

Majority of CHRONIC myeloid leukemia patients experience an adequate therapeutic effect from imatinib however, 26–37% of patients discontinue imatinib therapy due to a suboptimal response or intolerance. Here we investigated derivatives of apoptin, a chicken anemia viral protein with selective toxic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jangamreddy, Jaganmohan R., Panigrahi, Soumya, Lotfi, Kourosh, Yadav, Manisha, Maddika, Subbareddy, Tripathi, Anil Kumar, Sanyal, Sabyasachi, Łos, Marek J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2014
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196195/
https://ncbi.nlm.nih.gov/pubmed/25216532
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller